The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gemcitabine Injection Market Research Report 2024
Synopsis
Gemcitabine is used in combination with carboplatin to treat ovarian cancer (cancer that begins in the female reproductive organs where eggs are formed) that returned at least 6 months after finishing a previous treatment. It also used in combination with paclitaxel (Abraxane, Taxol) to treat breast cancer that has not improved or that has worsened after treatment with other medications. Gemcitabine is used in combination with cisplatin to treat a type of lung cancer (non-small cell lung cancer; NSCLC) that has spread to other parts of the body and cannot be treated with surgery. Gemcitabine is also used to treat pancreatic cancer that has spread to other parts of the body and has not improved or worsened after treatment with another medication. Gemcitabine is in a class of medications called antimetabolites. It works by slowing or stopping the growth of cancer cells in the body.
The global Gemcitabine Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gemcitabine Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gemcitabine Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gemcitabine Injection include Fresenius Kabi, Teva Pharmaceuticals, Pfizer, Mylan Inc, Novartis AG, Accord Healthcare and Meitheal Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gemcitabine Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gemcitabine Injection.
Report Scope
The Gemcitabine Injection market size, estimations, and forecasts are provided in terms of sales volume (KL) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gemcitabine Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gemcitabine Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fresenius Kabi
Teva Pharmaceuticals
Pfizer
Mylan Inc
Novartis AG
Accord Healthcare
Meitheal Pharmaceuticals
Segment by Type
200mg/5.26 mL
1g/26.3 mL
2g/52.6 mL
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gemcitabine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gemcitabine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Gemcitabine is used in combination with carboplatin to treat ovarian cancer (cancer that begins in the female reproductive organs where eggs are formed) that returned at least 6 months after finishing a previous treatment. It also used in combination with paclitaxel (Abraxane, Taxol) to treat breast cancer that has not improved or that has worsened after treatment with other medications. Gemcitabine is used in combination with cisplatin to treat a type of lung cancer (non-small cell lung cancer; NSCLC) that has spread to other parts of the body and cannot be treated with surgery. Gemcitabine is also used to treat pancreatic cancer that has spread to other parts of the body and has not improved or worsened after treatment with another medication. Gemcitabine is in a class of medications called antimetabolites. It works by slowing or stopping the growth of cancer cells in the body.
The global Gemcitabine Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gemcitabine Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gemcitabine Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gemcitabine Injection include Fresenius Kabi, Teva Pharmaceuticals, Pfizer, Mylan Inc, Novartis AG, Accord Healthcare and Meitheal Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gemcitabine Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gemcitabine Injection.
Report Scope
The Gemcitabine Injection market size, estimations, and forecasts are provided in terms of sales volume (KL) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gemcitabine Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gemcitabine Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fresenius Kabi
Teva Pharmaceuticals
Pfizer
Mylan Inc
Novartis AG
Accord Healthcare
Meitheal Pharmaceuticals
Segment by Type
200mg/5.26 mL
1g/26.3 mL
2g/52.6 mL
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gemcitabine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gemcitabine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Gemcitabine Injection Market Overview
1.1 Product Overview and Scope of Gemcitabine Injection
1.2 Gemcitabine Injection Segment by Type
1.2.1 Global Gemcitabine Injection Market Value Comparison by Type (2024-2030)
1.2.2 200mg/5.26 mL
1.2.3 1g/26.3 mL
1.2.4 2g/52.6 mL
1.3 Gemcitabine Injection Segment by Application
1.3.1 Global Gemcitabine Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Gemcitabine Injection Market Size Estimates and Forecasts
1.4.1 Global Gemcitabine Injection Revenue 2019-2030
1.4.2 Global Gemcitabine Injection Sales 2019-2030
1.4.3 Global Gemcitabine Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gemcitabine Injection Market Competition by Manufacturers
2.1 Global Gemcitabine Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gemcitabine Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gemcitabine Injection Average Price by Manufacturers (2019-2024)
2.4 Global Gemcitabine Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gemcitabine Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gemcitabine Injection, Product Type & Application
2.7 Gemcitabine Injection Market Competitive Situation and Trends
2.7.1 Gemcitabine Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gemcitabine Injection Players Market Share by Revenue
2.7.3 Global Gemcitabine Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gemcitabine Injection Retrospective Market Scenario by Region
3.1 Global Gemcitabine Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gemcitabine Injection Global Gemcitabine Injection Sales by Region: 2019-2030
3.2.1 Global Gemcitabine Injection Sales by Region: 2019-2024
3.2.2 Global Gemcitabine Injection Sales by Region: 2025-2030
3.3 Global Gemcitabine Injection Global Gemcitabine Injection Revenue by Region: 2019-2030
3.3.1 Global Gemcitabine Injection Revenue by Region: 2019-2024
3.3.2 Global Gemcitabine Injection Revenue by Region: 2025-2030
3.4 North America Gemcitabine Injection Market Facts & Figures by Country
3.4.1 North America Gemcitabine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gemcitabine Injection Sales by Country (2019-2030)
3.4.3 North America Gemcitabine Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gemcitabine Injection Market Facts & Figures by Country
3.5.1 Europe Gemcitabine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gemcitabine Injection Sales by Country (2019-2030)
3.5.3 Europe Gemcitabine Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gemcitabine Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Gemcitabine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gemcitabine Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Gemcitabine Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gemcitabine Injection Market Facts & Figures by Country
3.7.1 Latin America Gemcitabine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gemcitabine Injection Sales by Country (2019-2030)
3.7.3 Latin America Gemcitabine Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gemcitabine Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Gemcitabine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gemcitabine Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gemcitabine Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gemcitabine Injection Sales by Type (2019-2030)
4.1.1 Global Gemcitabine Injection Sales by Type (2019-2024)
4.1.2 Global Gemcitabine Injection Sales by Type (2025-2030)
4.1.3 Global Gemcitabine Injection Sales Market Share by Type (2019-2030)
4.2 Global Gemcitabine Injection Revenue by Type (2019-2030)
4.2.1 Global Gemcitabine Injection Revenue by Type (2019-2024)
4.2.2 Global Gemcitabine Injection Revenue by Type (2025-2030)
4.2.3 Global Gemcitabine Injection Revenue Market Share by Type (2019-2030)
4.3 Global Gemcitabine Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gemcitabine Injection Sales by Application (2019-2030)
5.1.1 Global Gemcitabine Injection Sales by Application (2019-2024)
5.1.2 Global Gemcitabine Injection Sales by Application (2025-2030)
5.1.3 Global Gemcitabine Injection Sales Market Share by Application (2019-2030)
5.2 Global Gemcitabine Injection Revenue by Application (2019-2030)
5.2.1 Global Gemcitabine Injection Revenue by Application (2019-2024)
5.2.2 Global Gemcitabine Injection Revenue by Application (2025-2030)
5.2.3 Global Gemcitabine Injection Revenue Market Share by Application (2019-2030)
5.3 Global Gemcitabine Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Fresenius Kabi
6.1.1 Fresenius Kabi Corporation Information
6.1.2 Fresenius Kabi Description and Business Overview
6.1.3 Fresenius Kabi Gemcitabine Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Fresenius Kabi Gemcitabine Injection Product Portfolio
6.1.5 Fresenius Kabi Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Corporation Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Gemcitabine Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceuticals Gemcitabine Injection Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Gemcitabine Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Gemcitabine Injection Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Mylan Inc
6.4.1 Mylan Inc Corporation Information
6.4.2 Mylan Inc Description and Business Overview
6.4.3 Mylan Inc Gemcitabine Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Inc Gemcitabine Injection Product Portfolio
6.4.5 Mylan Inc Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Corporation Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Gemcitabine Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis AG Gemcitabine Injection Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Accord Healthcare
6.6.1 Accord Healthcare Corporation Information
6.6.2 Accord Healthcare Description and Business Overview
6.6.3 Accord Healthcare Gemcitabine Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Accord Healthcare Gemcitabine Injection Product Portfolio
6.6.5 Accord Healthcare Recent Developments/Updates
6.7 Meitheal Pharmaceuticals
6.6.1 Meitheal Pharmaceuticals Corporation Information
6.6.2 Meitheal Pharmaceuticals Description and Business Overview
6.6.3 Meitheal Pharmaceuticals Gemcitabine Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Meitheal Pharmaceuticals Gemcitabine Injection Product Portfolio
6.7.5 Meitheal Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gemcitabine Injection Industry Chain Analysis
7.2 Gemcitabine Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gemcitabine Injection Production Mode & Process
7.4 Gemcitabine Injection Sales and Marketing
7.4.1 Gemcitabine Injection Sales Channels
7.4.2 Gemcitabine Injection Distributors
7.5 Gemcitabine Injection Customers
8 Gemcitabine Injection Market Dynamics
8.1 Gemcitabine Injection Industry Trends
8.2 Gemcitabine Injection Market Drivers
8.3 Gemcitabine Injection Market Challenges
8.4 Gemcitabine Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Gemcitabine Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Gemcitabine Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Gemcitabine Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Gemcitabine Injection Sales (KL) of Key Manufacturers (2019-2024)
Table 5. Global Gemcitabine Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Gemcitabine Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Gemcitabine Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Gemcitabine Injection Average Price (US$/L) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Gemcitabine Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gemcitabine Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gemcitabine Injection, Product Type & Application
Table 12. Global Key Manufacturers of Gemcitabine Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gemcitabine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gemcitabine Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gemcitabine Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Gemcitabine Injection Sales by Region (2019-2024) & (KL)
Table 18. Global Gemcitabine Injection Sales Market Share by Region (2019-2024)
Table 19. Global Gemcitabine Injection Sales by Region (2025-2030) & (KL)
Table 20. Global Gemcitabine Injection Sales Market Share by Region (2025-2030)
Table 21. Global Gemcitabine Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Gemcitabine Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Gemcitabine Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Gemcitabine Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Gemcitabine Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Gemcitabine Injection Sales by Country (2019-2024) & (KL)
Table 27. North America Gemcitabine Injection Sales by Country (2025-2030) & (KL)
Table 28. North America Gemcitabine Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Gemcitabine Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Gemcitabine Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Gemcitabine Injection Sales by Country (2019-2024) & (KL)
Table 32. Europe Gemcitabine Injection Sales by Country (2025-2030) & (KL)
Table 33. Europe Gemcitabine Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Gemcitabine Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Gemcitabine Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Gemcitabine Injection Sales by Region (2019-2024) & (KL)
Table 37. Asia Pacific Gemcitabine Injection Sales by Region (2025-2030) & (KL)
Table 38. Asia Pacific Gemcitabine Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Gemcitabine Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gemcitabine Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Gemcitabine Injection Sales by Country (2019-2024) & (KL)
Table 42. Latin America Gemcitabine Injection Sales by Country (2025-2030) & (KL)
Table 43. Latin America Gemcitabine Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gemcitabine Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gemcitabine Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Gemcitabine Injection Sales by Country (2019-2024) & (KL)
Table 47. Middle East & Africa Gemcitabine Injection Sales by Country (2025-2030) & (KL)
Table 48. Middle East & Africa Gemcitabine Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Gemcitabine Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Gemcitabine Injection Sales (KL) by Type (2019-2024)
Table 51. Global Gemcitabine Injection Sales (KL) by Type (2025-2030)
Table 52. Global Gemcitabine Injection Sales Market Share by Type (2019-2024)
Table 53. Global Gemcitabine Injection Sales Market Share by Type (2025-2030)
Table 54. Global Gemcitabine Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Gemcitabine Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Gemcitabine Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Gemcitabine Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Gemcitabine Injection Price (US$/L) by Type (2019-2024)
Table 59. Global Gemcitabine Injection Price (US$/L) by Type (2025-2030)
Table 60. Global Gemcitabine Injection Sales (KL) by Application (2019-2024)
Table 61. Global Gemcitabine Injection Sales (KL) by Application (2025-2030)
Table 62. Global Gemcitabine Injection Sales Market Share by Application (2019-2024)
Table 63. Global Gemcitabine Injection Sales Market Share by Application (2025-2030)
Table 64. Global Gemcitabine Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Gemcitabine Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Gemcitabine Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Gemcitabine Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Gemcitabine Injection Price (US$/L) by Application (2019-2024)
Table 69. Global Gemcitabine Injection Price (US$/L) by Application (2025-2030)
Table 70. Fresenius Kabi Corporation Information
Table 71. Fresenius Kabi Description and Business Overview
Table 72. Fresenius Kabi Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 73. Fresenius Kabi Gemcitabine Injection Product
Table 74. Fresenius Kabi Recent Developments/Updates
Table 75. Teva Pharmaceuticals Corporation Information
Table 76. Teva Pharmaceuticals Description and Business Overview
Table 77. Teva Pharmaceuticals Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 78. Teva Pharmaceuticals Gemcitabine Injection Product
Table 79. Teva Pharmaceuticals Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 83. Pfizer Gemcitabine Injection Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Mylan Inc Corporation Information
Table 86. Mylan Inc Description and Business Overview
Table 87. Mylan Inc Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 88. Mylan Inc Gemcitabine Injection Product
Table 89. Mylan Inc Recent Developments/Updates
Table 90. Novartis AG Corporation Information
Table 91. Novartis AG Description and Business Overview
Table 92. Novartis AG Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 93. Novartis AG Gemcitabine Injection Product
Table 94. Novartis AG Recent Developments/Updates
Table 95. Accord Healthcare Corporation Information
Table 96. Accord Healthcare Description and Business Overview
Table 97. Accord Healthcare Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 98. Accord Healthcare Gemcitabine Injection Product
Table 99. Accord Healthcare Recent Developments/Updates
Table 100. Meitheal Pharmaceuticals Corporation Information
Table 101. Meitheal Pharmaceuticals Description and Business Overview
Table 102. Meitheal Pharmaceuticals Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 103. Meitheal Pharmaceuticals Gemcitabine Injection Product
Table 104. Meitheal Pharmaceuticals Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Gemcitabine Injection Distributors List
Table 108. Gemcitabine Injection Customers List
Table 109. Gemcitabine Injection Market Trends
Table 110. Gemcitabine Injection Market Drivers
Table 111. Gemcitabine Injection Market Challenges
Table 112. Gemcitabine Injection Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gemcitabine Injection
Figure 2. Global Gemcitabine Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Gemcitabine Injection Market Share by Type in 2023 & 2030
Figure 4. 200mg/5.26 mL Product Picture
Figure 5. 1g/26.3 mL Product Picture
Figure 6. 2g/52.6 mL Product Picture
Figure 7. Global Gemcitabine Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Gemcitabine Injection Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global Gemcitabine Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Gemcitabine Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Gemcitabine Injection Sales (2019-2030) & (KL)
Figure 14. Global Gemcitabine Injection Average Price (US$/L) & (2019-2030)
Figure 15. Gemcitabine Injection Report Years Considered
Figure 16. Gemcitabine Injection Sales Share by Manufacturers in 2023
Figure 17. Global Gemcitabine Injection Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Gemcitabine Injection Players: Market Share by Revenue in 2023
Figure 19. Gemcitabine Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Gemcitabine Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Gemcitabine Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Gemcitabine Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Gemcitabine Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Gemcitabine Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Gemcitabine Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Gemcitabine Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Gemcitabine Injection Sales Market Share by Country (2019-2030)
Figure 44. Latin America Gemcitabine Injection Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Gemcitabine Injection Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Gemcitabine Injection Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Gemcitabine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Gemcitabine Injection by Type (2019-2030)
Figure 54. Global Revenue Market Share of Gemcitabine Injection by Type (2019-2030)
Figure 55. Global Gemcitabine Injection Price (US$/L) by Type (2019-2030)
Figure 56. Global Sales Market Share of Gemcitabine Injection by Application (2019-2030)
Figure 57. Global Revenue Market Share of Gemcitabine Injection by Application (2019-2030)
Figure 58. Global Gemcitabine Injection Price (US$/L) by Application (2019-2030)
Figure 59. Gemcitabine Injection Value Chain
Figure 60. Gemcitabine Injection Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
